Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

Jan Gerard Maring; Floris M. Wachters; Monique Slijfer; J. Marina Maurer; H. Marike Boezen; Donald R. A. Uges; Elisabeth G. E. Vries; Harry J. M. Groen

doi:10.1007/s00228-010-0799-0

Journal articles

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

Jan Gerard Maring ^{1, *} Floris M. Wachters ² Monique Slijfer ³ J. Marina Maurer ⁴ H. Marike Boezen ⁵ Donald R. A. Uges ⁴ Elisabeth G. E. Vries ⁶ Harry J. M. Groen ²

* Corresponding author

1 Department of Pharmacy

2 Department of Pulmonary Medicine

3 Department of Pharmacy

4 Department of Pharmacy

5 Department of Epidemiology

6 Department of Medical Oncology

Keywords : Gemcitabine Cytidine deaminase Pharmacogenetics Pharmacokinetics Genetic polymorphism

Document type :

Journal articles

Complete list of metadata

Cited literature [23 references] Display Hide Download

https://hal.archives-ouvertes.fr/hal-00612989
Contributor : Hal Peer Connect in order to contact the contributor
Submitted on : Tuesday, August 2, 2011 - 3:26:47 AM
Last modification on : Thursday, May 2, 2019 - 2:00:22 PM
Long-term archiving on: : Sunday, December 4, 2016 - 5:53:37 PM

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

File

Identifiers

Collections

Citation

Export

Metrics

25

93

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

File

Identifiers

Collections

Citation

Export

Share

Metrics

25

93